Juvenile mycosis fungoides: Cutaneous T-cell lymphoma with frequent follicular involvement - 14/05/14
, Iris Amitay-Laish, MD a, Meora Feinmesser, MD b, f, Batya Davidovici, MD, MSc a, Michael David, MD a, f, Alex Zvulunov, MD, MHA c, g, Felix Pavlotsky, MD e, f, Isaac Yaniv, MD d, f, Gali Avrahami, MD d, f, Dan Ben-Amitai, MD c, fAbstract |
Background |
The literature on mycosis fungoides (MF) in children/adolescents is sparse.
Objective |
We sought to evaluate the characteristics of juvenile MF in a large cohort.
Methods |
Data were collected on all patients with MF, aged 18 years or younger at the time of clinicopathologic diagnosis, who attended the Rabin Medical Center Dermatology Department, Petach Tikva, Israel, between 1994 and 2012 and were followed up prospectively.
Results |
There were 50 patients (30 male; mean age 11.4 years at diagnosis); 18 (36%) had Fitzpatrick skin type IV or higher. All were given a diagnosis of early-stage disease (IA-IIA) except 1 (tumor stage, IIB). Eight had classic MF lesions only and 42 had other variants, alone or in combination; these were mainly hypopigmented MF (n = 29) and cases with subtle but clear clinicopathologic features of folliculotropic MF (FMF) (n = 18). Among the various skin-targeted therapies, psoralen plus ultraviolet A (systemic/bath) proved beneficial for FMF. During a follow-up period of 0.25 to 15 years (mean 4.5), 2 patients progressed from stage IA to IB or IIA.
Limitations |
Relatively short follow-up is a limitation.
Conclusions |
This case series shows that FMF is not uncommon in children and adolescents. It is characterized by more superficial clinical features and less heavy perifollicular lymphocytic infiltrates than adult FMF, and responds well to psoralen plus ultraviolet A. The prognosis of childhood FMF remains unclear.
Le texte complet de cet article est disponible en PDF.Key words : children, cutaneous lymphoma, folliculotropic mycosis fungoides, juvenile, mycosis fungoides, pediatric
Abbreviations used : EORTC, FMF, FST, MF, NBUVB, PUVA, UV, WHO
Plan
| Funding sources: None. |
|
| Drs Hodak and Amitay-Laish contributed equally to this article. |
|
| Conflicts of interest: None declared. |
Vol 70 - N° 6
P. 993-1001 - juin 2014 Retour au numéro
Article précédent
- Change of Address
- Cutaneous extranodal natural killer/T-cell lymphoma: A comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site
- Woo Jin Lee, Joon Min Jung, Chong Hyun Won, Sung Eun Chang, Jee Ho Choi, Kee Chan Moon, Chan-Sik Park, Jooryung Huh, Mi Woo Lee
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?